首页 › 基金 › EcoR1 Capital, LLC › LKFT
EcoR1 Capital, LLC 对 LKFT 的持仓历史
LAKEFRONT BIOTHERAPEUTICS NV
EcoR1 Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 LKFT(LAKEFRONT BIOTHERAPEUTICS NV)1,667,119 股,市值约 US$49.4M,约占其申报组合的 2.34%,在其申报持仓中市值排名第 9 位。 EcoR1 Capital, LLC 最近 13 个申报季度中有 13 个季度披露了 LKFT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
EcoR1 Capital, LLC 对 LKFT 的持仓演变
EcoR1 Capital, LLC 于 Q3 2023 首次披露 LKFT 持仓:5,756,268 股(约 US$198.9M)。 该持仓在 Q4 2023 达到峰值 5,756,268 股,市值约 US$234.0M。 在 13 次申报中,EcoR1 Capital, LLC 2 次增持、1 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 1,667,119 股、市值约 US$49.4M。 持仓曾出现大幅变动:Q3 2024 减持约 97% (随后一个季度股价下跌 4%)、Q2 2025 增持约 569% (随后一个季度股价上涨 24%)、Q3 2025 增持约 61% (随后一个季度股价下跌 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 5.76M | $198.88M | 新进 |
| Q4 2023 | 5.76M | $233.99M | 持有 |
| Q1 2024 | 5.76M | $185.35M | 持有 |
| Q2 2024 | 5.76M | $142.64M | 持有 |
| Q3 2024 | 155.01K | $4.46M | 减持 |
| Q4 2024 | 155.01K | $4.26M | 持有 |
| Q1 2025 | 155.01K | $3.89M | 持有 |
| Q2 2025 | 1.04M | $29.02M | 增持 |
| Q3 2025 | 1.67M | $57.75M | 增持 |
| Q4 2025 | 1.67M | $54.51M | 持有 |
| Q1 2026 | 1.67M | $50.01M | 持有 |
| Q2 2026 | 1.67M | $49.98M | 持有 |
| Q3 2026 | 1.67M | $49.43M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LKFT 与 13F 数据
LKFT(LAKEFRONT BIOTHERAPEUTICS NV)的行业分类暂缺。我们追踪的基金中还有 18 只申报持有 LKFT,申报仓位最大的包括:GILEAD SCIENCES, INC. (US$501.3M), TANG CAPITAL MANAGEMENT LLC (US$113.5M), Madison Avenue Partners, LP (US$104.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LKFT 的基金
- GILEAD SCIENCES, INC. 16.71M 股 · $501.28M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 3.79M 股 · $113.50M · Q2 2026
- Madison Avenue Partners, LP 3.52M 股 · $104.25M · Q3 2026
- Prosight Management, LP 2.00M 股 · $59.25M · Q3 2026
- DME Capital Management, LP 482.75K 股 · $14.47M · Q2 2026
- DAFNA Capital Management LLC 130.18K 股 · $3.90M · Q2 2026
更多关于 EcoR1 Capital, LLC
常见问题
How long has EcoR1 Capital, LLC held LKFT?
EcoR1 Capital, LLC has disclosed LKFT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EcoR1 Capital, LLC's current position in LKFT?
As of Q3 2026, EcoR1 Capital, LLC holds 1.67M shares of LKFT (LAKEFRONT BIOTHERAPEUTICS NV), valued at $49.43M, representing 2.34% of its reported portfolio and ranking #9.
Has EcoR1 Capital, LLC been buying or selling LKFT?
In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC held unchanged its position in LKFT. The position peaked in Q4 2023 at 5.76M shares.
Which other funds hold LKFT?
Other major institutional holders of LKFT include GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.